These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8172220)

  • 1. The successful treatment of recurrent nephrotic syndrome with the MOPP regimen in a patient with a remote history of Hodgkin's disease.
    Delmez JA; Safdar SH; Kissane JM
    Am J Kidney Dis; 1994 May; 23(5):743-6. PubMed ID: 8172220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical case of the month. The association of Hodgkin's disease and nephrotic syndrome].
    Baron F; Hermanne JP; Fassotte MF; Beguin Y; Fillet G
    Rev Med Liege; 1998 Nov; 53(11):651-3. PubMed ID: 9887654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerulonephritis preceding late relapse of Hodgkin's disease.
    Lynn WA; Marcus RE
    Postgrad Med J; 1988 May; 64(751):395-7. PubMed ID: 3200784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hodgkin's disease complicated by the nephrotic syndrome in a man with Kugelberg-Welander disease.
    Thomson JA; Seymour JF; Wolf M
    Leuk Lymphoma; 2001 Jul; 42(3):561-6. PubMed ID: 11699426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Four cases of Hodgkin's disease treated with MOPP/ABV hybrid regimen using nitrogen mustard-N-oxide hydrochloride].
    Kozai Y; Ohyama T; Kodo H; Tomori G
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2407-9. PubMed ID: 1281397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal segmental glomerulosclerosis in Hodgkin's disease.
    Watson A; Stachura I; Fragola J; Bourke E
    Am J Nephrol; 1983; 3(4):228-32. PubMed ID: 6688503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
    Canellos GP
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MOPP therapy of Hodgkin's disease previously treated with MOPP].
    Frau A; Montalar J
    Med Clin (Barc); 1985 May; 84(19):801. PubMed ID: 3839875
    [No Abstract]   [Full Text] [Related]  

  • 9. Mopp chemotherapy in the treatment of stage IV Hodgkin's disease.
    Fiacchini M; Lauria F; Mazza P; Cantore M; Gherlinzoni F; Tura S
    Haematologica; 1985; 70(2):148-54. PubMed ID: 3924778
    [No Abstract]   [Full Text] [Related]  

  • 10. [CVP or C-MOPP combination chemotherapy in the treatment of advanced Hodgkin's disease and non-Hodgkin's lymphoma (intermediate grade of working formulation)].
    Sampi K; Honda T; Hattori M
    Rinsho Ketsueki; 1984 Feb; 25(2):164-8. PubMed ID: 6547984
    [No Abstract]   [Full Text] [Related]  

  • 11. Hodgkin's disease presenting as nephrotic syndrome.
    Agarwal S; Avasthi R; Tyagi SC; Singh K; Ram BK
    J Assoc Physicians India; 1994 Nov; 42(11):907-8. PubMed ID: 7868497
    [No Abstract]   [Full Text] [Related]  

  • 12. British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease--long term results.
    Hancock BW; Vaughan Hudson G; Vaughan Hudson B; Haybittle JL; Bennett MH; MacLennan KA; Jelliffe AM
    Br J Cancer; 1991 Apr; 63(4):579-82. PubMed ID: 2021542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
    Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.
    Connors JM; Klimo P; Adams G; Burns BF; Cooper I; Meyer RM; O'Reilly SE; Pater J; Quirt I; Sadura A; Shustik C; Skillings J; Sutcliffe S; Verma S; Yoshida S; Zee B
    J Clin Oncol; 1997 Apr; 15(4):1638-45. PubMed ID: 9193364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Hodgkin lymphoma following Hodgkin's disease. A case report.
    Heinz R; Hanak H
    Blut; 1984 Oct; 49(4):353-7. PubMed ID: 6548395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hodgkin's disease with systemic vasculitis and Lambert-Eaton myasthenic syndrome--case report].
    Homenda W; Hellmann A
    Wiad Lek; 2000; 53(9-10):574-8. PubMed ID: 11148928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipoid nephrosis in a child with advanced Hodgkin's lymphoma].
    Gordillo Paniagua G; Velázquez Jones L; Scovino Gudiño R; Arroyo Sierra J; Silva Sosa M; Mota Hernández F
    Bol Med Hosp Infant Mex; 1977; 34(4):815-21. PubMed ID: 911442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-Hodgkin's lymphoma in a patient after many years of remission of Hodgkin's disease].
    Kaźmierczak M; Komarnicki M; Kroll R
    Acta Haematol Pol; 1995; 26(3):311-3. PubMed ID: 8525778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlorambucil, vinblastine, procarbazine, and prednisone. An effective but less toxic regimen than MOPP for advanced-stage Hodgkin's disease.
    Druker BJ; Rosenthal DS; Canellos GP
    Cancer; 1989 Mar; 63(6):1060-4. PubMed ID: 2917308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD?
    Canellos GP
    Leukemia; 1996 Jun; 10 Suppl 2():s68. PubMed ID: 8649055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.